Article Text
Statistics from Altmetric.com
Primary ciliary dyskinesia (PCD), an inherited motile ciliopathy, is characterised by recurrent upper and lower respiratory tract infections, organ laterality defects, subfertility and neonatal respiratory distress due to impaired ciliary function.1 Over 50 PCD disease-causing genes have been identified that impact the structure and function of the cilia (figure 1, originally in Despotes et al1). Significant clinical heterogeneity is associated with PCD, in part driven by genotype; genotype–phenotype relationships are an emerging area of great importance within this rare disease.2–4 However, clinical heterogeneity has also been reported among patients with the same genetic variants,3 suggesting that genetic modifiers may play an important role in disease manifestations. In their Thorax paper, Pifferi and colleagues have helped uncover our incomplete understanding of this heterogeneity by evaluating the impact of TAS2R38 polymorphisms within specific PCD genotypes. The authors specifically explored the impact of these polymorphisms on Pseudomonas aeruginosa (PA) infections, lung function and nasal nitric oxide (nNO) levels.5
Footnotes
Contributors KAD guarantees that all authors (KAD, SDD) made contributions to the conception of work, drafting and revising of work, final approval of the version to be published and agreement to be accountable for aspects of the work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests SDD: Research support—National Institutes of Health (HL096458, TR004057); observational study research support—ReCode Therapeutics. Clinical advisory board and consultancies: PCD Foundation, Medical and Scientific Advisory Council; Chair, American Thoracic Society Publications Policy Committee (unpaid).
Provenance and peer review Commissioned; internally peer reviewed.